- Office of Sponsored Programs
- Export Controls
- Misconduct in Scholarship (Ethical Conduct)
- NCURA YouTube
- Reporting Research Misconduct
- Reporting Unethical Behavior
- Institutional Review Board
- IRB Forms
- Required Education
- Research with Other Organizations
- Tips for Researchers
- Policies & Procedures
- Meeting Schedule
- Research Participants
- Animal Care and Use
- Conflict of Interest
- Institutional Biosafety
- Radiation Safety & Hazardous Materials
- Unmanned Aircraft Systems
Institutional Biosafety Committee (IBC)
Institutional Biosafety Committee (IBC)
The University of North Dakota Institutional Biosafety Committee (IBC) requires that any biological research or teaching activities, particularly those utilizing DNA, recombinant DNA, transgenic organisms, or biohazardous research material, be subject to a University Review Process and that these activities must be approved by the IBC prior to their initiation. The IBC is the only authorized University committee that can give approval to projects and activities involving DNA, recombinant DNA and biohazardous research material. The IBC will follow UND laboratory biosafety guidelines and the NIH guidelines for DNA, recombinant DNA and biohazardous material research in determining the suitability of projects and activities. For any proposed activity not approved by the IBC, an explanation of that decision will be provided. Any project or activity not approved can be revised and resubmitted to the IBC for consideration.
IBC Application Process
All faculty or staff who plan on using recombinant DNA, biohazardous materials or conducting activities that involve the handling of biological materials in a research setting (live or dead animals, plant or animal pathogens, tissue, blood, bodily secretions, nucleic acids, toxins, etc.), teaching, or other activities must submit a completed, signed application form to:
University of North Dakota
Twamley Hall Room 106
264 Centennial Drive Stop 7134
Grand Forks, ND 58202-7134
One copy of all funded grant applications utilizing recombinant DNA or biohazardous materials must be submitted to the IBC with the application. The PI will not be able to access grant funds or begin the project until the IBC has reviewed and approved the project. Any changes to an approved project must receive IBC approval prior to their implementation.
All approved projects must be reviewed on an annual basis, and any significant protocol changes must be submitted for approved, as well.
IBC Membership - 2016 - 2017
||Term Start Date||Highest Degree||Scientific Specialty||Affiliation with UND|
|David Bradley||5/5/08||Ph.D.||Microbiology||Associate Professor, Biomedical Sciences
|Lucia Carvelli||5/1/11||Ph.D.||Physiology||Assistant Professor, Biomedical Sciences
|Scott Garrett2||4/5/05||Ph.D.||Pathology||Associate Professor, Pathology
|Sumit Ghosh||8/1/15||Ph.D.||Microbiology; Immunology; Biotechnology; Cellular & Molecular Biology||Biological Safety Officer
|Barry Milavetz4||Ex Officio||Ph.D.||Biochemistry||Associate Vice President for Research & Economic Development
|Matthew L. Nilles1||11/15/01||Ph.D.||Microbiology; Bacterial Pathogenesis||Associate Professor, Biomedical Sciences
|Garry A. Pearson3||11/18/87||J.D.||Attorney||Community Member
|James E. Porter||4/22/03||Ph.D||Pharmacology||Associate Professor, Biomedical Sciences
|Steven G. Ralph||12/15/09||Ph.D.||Molecular Biology||Associate Professor, Biology
|Linda M. Ray||8/25/97||M.L.S.||Clinical Laboratory Science||Assistant Professor, Medical Laboratory Science
|Jefferson A. Vaughan||5/14/03||Ph.D.||Medical Entomology and Vector-Borne Diseases||Professor, Biology
|Min Wu||5/1/11||Ph.D.||Infection and Immunity Cell and Molecular Biology, Nanomedicine||Professor, Biomedical Sciences
|Terry Wynne||3/1/14||B.A.||Campus Safety & Security||Associate Director for Safety
IBC Research Registration Application: To be completed by all investigators conducting biological research.
IBC Instructional Registration Application: To be completed by anyone using biological materials for educational or instructional purposes.
IBC Protocol Change and Annual Review Form: To be completed annually by all investigators conducting biological research or when initiating a change to an approved IBC protocol.
IBC Adverse Event Reporting Form: To be completed within 24 hours of an adverse event occurring on an approved IBC protocol.
Policies and Manuals
Bloodborne Pathogens Training
Who Needs to Complete this Training?
Bloodborne pathogens training is mandatory for all laboratory investigators working with exposed blood, blood components, or any unfixed human tissue; and for other employees whose job responsibilities may expose them to such materials.
Any person who handles blood or certain other body fluids as part of their job, or whose job responsibilities include activities that might expose them to such body fluids is required to understand the potential hazards of such exposure and receive bloodborne pathogens training. This training, Protection Against Bloodborne Pathogens, is provided in the accompanying manual and must be completed before initial exposure on the job, and at least annually thereafter. Training is also required when there has been a change in job duties and responsibilities by which there is a potential exposure to bloodborne pathogens.
This training consists of an online class presented by UND's Environmental Health and Safety Office that covers an explanation of the OSHA Standard, epidemiology and transmission of bloodborne pathogens, and appropriate work practices, procedures, and measures to control exposure. After watching the class, laboratory investigators and employees must take the bloodborne pathogens training test (below), which must be completed and returned to the office of Research Development & Compliance, Stop 7134.
UND Exposure Control Plan